Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Lobbyist name (consultant or in-house lobbyist): BEAUCHAMP, NORMA OR;
  2. Responsible officer name: BEAUCHAMP, NORMA
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (7)
Results: 1-7 | Export
  1. Cystic Fibrosis Canada / Fibrose kystique Canada
    Type: In-house Organization
    Responsible officer: Norma Beauchamp, President and Chief Executive Officer
    Registration: 14 of 30 (2017-09-01 to 2017-11-03)
    Posted: 2017-09-01
    Subject matter details: 8
    Government institutions: 10
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  2. Cystic Fibrosis Canada / Fibrose kystique Canada
    Type: In-house Organization
    Responsible officer: Norma Beauchamp, President and Chief Executive Officer
    Registration: 13 of 30 (2017-02-06 to 2017-09-01)
    Posted: 2017-02-09
    Subject matter details: 4
    Government institutions: 10
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  3. Cystic Fibrosis Canada / Fibrose kystique Canada
    Type: In-house Organization
    Responsible officer: Norma Beauchamp, President and Chief Executive Officer
    Registration: 12 of 30 (2016-04-19 to 2017-02-06)
    Posted: 2016-10-04
    Subject matter details: 4
    Government institutions: 10
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 3
  4. Bayer Inc.
    Type: In-house Corporation
    Responsible officer: Philip Blake, President and CEO
    Registration: 6 of 27 (2008-03-14 to 2009-07-02)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 6
    Government funding: No
    Employees who lobby: 19
  5. Bayer Inc.
    Type: In-house Corporation
    Responsible officer: Philip Blake, President and CEO
    Registration: 5 of 27 (2007-10-25 to 2008-03-14)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 6
    Government funding: No
    Employees who lobby: 21
  6. Bayer Inc.
    Type: In-house Corporation
    Responsible officer: Philip Blake, President and CEO
    Registration: 4 of 27 (2007-03-23 to 2007-10-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 6
    Government funding: No
    Employees who lobby: 17
  7. Bayer Inc.
    Type: In-house Corporation
    Responsible officer: Philip Blake, President and CEO
    Registration: 3 of 27 (2006-09-18 to 2007-03-23)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 3
    Government institutions: 57
    Communication techniques: 6
    Government funding: No
    Employees who lobby: 17
Date Modified: